Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease

Denise L. Jacobson, Albert W Wu, Judith Feinberg

Research output: Contribution to journalArticle

Abstract

We tested whether health related quality of life (HRQOL) predicts mortality, development of active cytomegalovirus (CMV) disease, and study retention. We studied 957 patients with CD4 counts 3 in AIDS Clinical Trials Group Protocol 204, a randomized, double-blind trial comparing three prophylactic regimens against CMV end-organ disease. The MOS-HIV, a brief HRQOL questionnaire, generated physical health summary (PHS) and mental health summary (MHS) scores. We used Cox proportional hazards to predict events by baseline HRQOL, adjusted for treatment, demographics, and CD4. Each point increase in baseline PHS decreased the risk of death by 4%, CMV by 2%, and dropout by 2%. Each point increase in baseline MHS decreased the risk of death by 4% and study dropout by 1%. In conclusion, self-rated physical and mental health demonstrated predictive validity for survival, CMV end-organ disease, and retention in advanced HIV patients. The results show the clinical importance of HRQOL and may facilitate interpretation by clinicians.

Original languageEnglish (US)
Pages (from-to)874-879
Number of pages6
JournalJournal of Clinical Epidemiology
Volume56
Issue number9
DOIs
StatePublished - Sep 1 2003

Fingerprint

Cytomegalovirus
Quality of Life
Clinical Trials
HIV
Mental Health
Survival
Health
CD4 Lymphocyte Count
Clinical Protocols
Acquired Immunodeficiency Syndrome
Demography
Mortality
Therapeutics

Keywords

  • Clinical trial
  • Cytomegalovirus
  • Health-related quality of life
  • Outcomes
  • Study retention
  • Survival

ASJC Scopus subject areas

  • Medicine(all)
  • Public Health, Environmental and Occupational Health
  • Epidemiology

Cite this

Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease. / Jacobson, Denise L.; Wu, Albert W; Feinberg, Judith.

In: Journal of Clinical Epidemiology, Vol. 56, No. 9, 01.09.2003, p. 874-879.

Research output: Contribution to journalArticle

@article{a22376e8089c468ca6c37e1dc66eaa3a,
title = "Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease",
abstract = "We tested whether health related quality of life (HRQOL) predicts mortality, development of active cytomegalovirus (CMV) disease, and study retention. We studied 957 patients with CD4 counts 3 in AIDS Clinical Trials Group Protocol 204, a randomized, double-blind trial comparing three prophylactic regimens against CMV end-organ disease. The MOS-HIV, a brief HRQOL questionnaire, generated physical health summary (PHS) and mental health summary (MHS) scores. We used Cox proportional hazards to predict events by baseline HRQOL, adjusted for treatment, demographics, and CD4. Each point increase in baseline PHS decreased the risk of death by 4{\%}, CMV by 2{\%}, and dropout by 2{\%}. Each point increase in baseline MHS decreased the risk of death by 4{\%} and study dropout by 1{\%}. In conclusion, self-rated physical and mental health demonstrated predictive validity for survival, CMV end-organ disease, and retention in advanced HIV patients. The results show the clinical importance of HRQOL and may facilitate interpretation by clinicians.",
keywords = "Clinical trial, Cytomegalovirus, Health-related quality of life, Outcomes, Study retention, Survival",
author = "Jacobson, {Denise L.} and Wu, {Albert W} and Judith Feinberg",
year = "2003",
month = "9",
day = "1",
doi = "10.1016/S0895-4356(03)00062-3",
language = "English (US)",
volume = "56",
pages = "874--879",
journal = "Journal of Clinical Epidemiology",
issn = "0895-4356",
publisher = "Elsevier USA",
number = "9",

}

TY - JOUR

T1 - Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease

AU - Jacobson, Denise L.

AU - Wu, Albert W

AU - Feinberg, Judith

PY - 2003/9/1

Y1 - 2003/9/1

N2 - We tested whether health related quality of life (HRQOL) predicts mortality, development of active cytomegalovirus (CMV) disease, and study retention. We studied 957 patients with CD4 counts 3 in AIDS Clinical Trials Group Protocol 204, a randomized, double-blind trial comparing three prophylactic regimens against CMV end-organ disease. The MOS-HIV, a brief HRQOL questionnaire, generated physical health summary (PHS) and mental health summary (MHS) scores. We used Cox proportional hazards to predict events by baseline HRQOL, adjusted for treatment, demographics, and CD4. Each point increase in baseline PHS decreased the risk of death by 4%, CMV by 2%, and dropout by 2%. Each point increase in baseline MHS decreased the risk of death by 4% and study dropout by 1%. In conclusion, self-rated physical and mental health demonstrated predictive validity for survival, CMV end-organ disease, and retention in advanced HIV patients. The results show the clinical importance of HRQOL and may facilitate interpretation by clinicians.

AB - We tested whether health related quality of life (HRQOL) predicts mortality, development of active cytomegalovirus (CMV) disease, and study retention. We studied 957 patients with CD4 counts 3 in AIDS Clinical Trials Group Protocol 204, a randomized, double-blind trial comparing three prophylactic regimens against CMV end-organ disease. The MOS-HIV, a brief HRQOL questionnaire, generated physical health summary (PHS) and mental health summary (MHS) scores. We used Cox proportional hazards to predict events by baseline HRQOL, adjusted for treatment, demographics, and CD4. Each point increase in baseline PHS decreased the risk of death by 4%, CMV by 2%, and dropout by 2%. Each point increase in baseline MHS decreased the risk of death by 4% and study dropout by 1%. In conclusion, self-rated physical and mental health demonstrated predictive validity for survival, CMV end-organ disease, and retention in advanced HIV patients. The results show the clinical importance of HRQOL and may facilitate interpretation by clinicians.

KW - Clinical trial

KW - Cytomegalovirus

KW - Health-related quality of life

KW - Outcomes

KW - Study retention

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=0141849360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141849360&partnerID=8YFLogxK

U2 - 10.1016/S0895-4356(03)00062-3

DO - 10.1016/S0895-4356(03)00062-3

M3 - Article

C2 - 14505773

AN - SCOPUS:0141849360

VL - 56

SP - 874

EP - 879

JO - Journal of Clinical Epidemiology

JF - Journal of Clinical Epidemiology

SN - 0895-4356

IS - 9

ER -